510(k) K772327

LAS-R HUMAN IGD TEST by Hyland Therapeutic Div., Travenol Laboratories — Product Code CZJ

K772327 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LAS-R HUMAN IGD TEST". The FDA issued a decision of Substantially Equivalent on February 28, 1978. The device falls under product code CZJ (Igd, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5510. Hyland Therapeutic Div., Travenol Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 28, 1978
Date Received
December 21, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Igd, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5510
Review Panel
IM
Submission Type